Jews patented the cure for the mRNA vaccines in 2017

 

>As used herein, the terms "microRNA" or "miR" refer to small non-coding RNA molecule, that contains 18-25 nucleotide (usually between 20-23, and most commonly 22), that binds to at least one mRNA target and inhibits protein expression from that mRNA. miRs are well known to one skilled in the art, and frequently target many mRNAs although not all targets of specific miRs are yet known. In some embodiments, the miR reduces protein produced by an mRNA by at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 99%. Each possibility represents a different embodiment of the invention.

 

> In some embodiments, the polynucleotide inhibitor reduces miR suppression of translation of an mRNA by at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 99%. Each possibility represents a different embodiment of the invention. In some embodiments, the methods of the invention further comprise ectopically expressing within the differentiated cancer cell a polynucleotide inhibitor of miR-3180.

 

Has a lot of wild claims:

 

>The term "cancer vaccine" as used herein refers to a composition that improves immunity to cancer, or activates the immune system again cancer cells. In some embodiments, a cancer vaccine is adapted to stimulate the immune system to attack cells of the cancer.

 

Just because they filed the patent doesn't mean it works.

 

Inventors: Brodie; Chaya (Southfield, MI), Brodie; Shlomit (Nof Ayalon, IL)

 

Applicant:

 

Name City State Country Type

 

EXOSTEM BIOTEC LTD.

 

Tel Aviv

 

N/A

 

IL

 

Assignee: EXOSTEM BIOTEC LTD. (Tel Aviv, IL)

 

Family ID: 59684865

 

Appl. No.: 16/079,279

 

Filed: February 23, 2017

 

United States Patent 11,053,476

 

Brodie , et al. July 6, 2021

 

Same inventors:

 

>10,034,902 7/31/18

 

>MicroRNAs for the generation of astrocytes

 

United States Patent 10,034,902

 

Brodie , et al. July 31, 2018

 

Inventors: Brodie; Chaya (Southfield, MI), Slavin; Shimon (Tel-Aviv, IL)

 

Applicant:

 

Name City State Country Type

 

BrainStem Biotec Ltd.

 

Henry Ford Health System

 

Tel-Aviv

 

Detroit

 

N/A

 

MI

 

IL

 

US

 

Assignee: EXOSTEM BIOTEC LTD. (Tel-Aviv, IL)

 

HENRY FORD HEALTH SYSTEM (Detroit, MI)

 

miR has the potential to stop the 40 trillion mRNA molecules; thus inhibiting the spike protein production

 

It means they poison the host population natural immune system and health. And then offer up a cure for exorbitant prices.

 

Basic mafia shit.